Association between serum S100A11 levels and glucose metabolism in diabetic process

• Published in: Diabetology and metabolic syndrome 2023-03, Vol.15 (1), p.36-36, Article 36
• Main Authors: Wu, Yao, Wu, Shaobo, Li, Fang, Zeng, Ting, Luo, Xiaohe
• Format: Article
• Language: English
• Subjects: Analysis; Body mass index; Dextrose; Diabetes; Diabetes mellitus; Gender; Gene expression; Glucose; Glucose metabolism; Glucose tolerance; Glucose tolerance tests; Glycosylated hemoglobin; HbA1c; Hemoglobin; Impaired glucose tolerance; Insulin; Insulin resistance; Kidneys; Liver; Metabolic disorders; Metabolism; mRNA; Patients; Physiological aspects; Regression analysis; RNA; S100A11; Serum levels
• ISSN: 1758-5996; 1758-5996
• DOI: 10.1186/s13098-023-01004-1

Diabetes mellitus (DM) is a prevalent non-communicable metabolic disease, and S100A11 is a newly identified gene closely related to metabolism. The association of S100A11 with diabetes is unclear. This study aimed to assess the relationship between S100A11 and markers of glucose metabolism in patients with different glucose tolerance and gender. This study included 97 participants. Baseline data were obtained, and the serum levels of S100A11 and metabolic markers (glycated hemoglobin [HbA1c], insulin release test, and oral glucose tolerance test) were measured. Linear and nonlinear correlations between serum S100A11 levels and HOMA-IR, HOMA of β, HbA1c, insulin sensitivity index (ISI), corrected insulin response (CIR), and oral disposition index (DIo) were analyzed. The expression of S100A11 was also detected in mice. Serum S100A11 levels increased in patients with impaired glucose tolerance (IGT) of both genders. S100A11 mRNA and protein expression increased in obese mice. There were nonlinear correlations between S10011 levels and CIR, FPI, HOMA-IR, whole-body ISI in the IGT group. S100A11 was nonlinearly correlated with HOMA-IR, hepatic ISI, FPG, FPI, and HbA1c in the DM group. In the male group, S100A11 was linearly correlated with HOMA-IR and nonlinearly correlated with DIo (derived from hepatic ISI) and HbA1c. In the female population, S100A11 was nonlinearly correlated with CIR. Serum S100A11 levels were highly expressed in patients with IGT and in the liver of obese mice. In addition, there were linear and nonlinear correlations between S100A11 and markers of glucose metabolism, demonstrating that S100A11 has a role in diabetes. Trial registration ChiCTR1900026990.